Johnson & Johnson's Janssen Unit Ordered to Pay US About $1.64 Billion in HIV Drug Marketing Case

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Johnson & Johnson's Janssen Unit Ordered to Pay US About $1.64 Billion in HIV Drug Marketing Case

, MT Newswires - 2:02 PM ET 3/28/2025 default

02:02 PM EDT, 03/28/2025 (MT Newswires) -- A federal district court judge in New Jersey ordered Johnson & Johnson's ( JNJ ) Janssen Products unit on Friday to pay the US government $1.64 billion in damages and civil penalties after a jury found the unit liable for "unlawfully promoting" two HIV/AIDS drugs last year.

Johnson & Johnson ( JNJ ) did not immediately reply to a request for comment from MT Newswires.

Price: 164.34, Change: +1.21, Percent Change: +0.74

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.